| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Medical and professional news |
| Population | Men |
| Source | Doctors.net.uk |
| URL | doctors.net.uk/news/high-and-low-testosterone-appear-to-increase-af-risk (opens in a new tab) |
Specific Claim Evaluated
Both low and high testosterone may be associated with increased atrial fibrillation risk, and men on testosterone therapy should be treated to the middle of the normal range with hematocrit monitoring.
Primary Research Supporting or Contradicting the Claim
An updated review supports a U-shaped association between testosterone and atrial fibrillation (Maligireddy et al., 2026). Atrial fibrillation was more common with testosterone than placebo in TRAVERSE (Lincoff et al., 2023), and guidelines recommend a mid-normal on-treatment target with hematocrit monitoring (Bhasin et al., 2018).
Corrected Evidence-Based Interpretation
The report is correct. The association with high testosterone does not establish that physiologic replacement causes atrial fibrillation in every patient, but it supports conservative dosing.
Rationale for Grade
The article uses associational language, attributes the dosing advice to the review authors and is consistent with guideline recommendations on target range and hematocrit. It is a brief professional summary and does not overstate the review.
References
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID
Supporting excerpt: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs" - Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. PMID
Supporting excerpt: "noninferior to placebo with respect to the incidence of major adverse cardiac events" - Maligireddy AR, Barua ST, Barua RS. Association of testosterone and testosterone replacement therapy with atrial fibrillation: an updated review. J Endocr Soc. 2026;10(9):bvag180. PMID
Supporting excerpt: "Converging evidence thus supports a U-shaped T-AF relationship."